Richard A. Johnson
Rick Johnson is the CEO and Founder of Global Helix LLC, a consulting and government strategy firm based in Washington, D.C. Rick has worked extensively on the linkage of global developments and strategies with fundamental research, innovation and entrepreneurship. After 30 years, he retired as Senior Partner in the Washington, D.C. office of Arnold & Porter LLP but continues to serve as Senior Counsel. He specializes in: (1) legal and regulatory issues related to fundamental research, innovation and collaborative mechanisms; and (2) new research, public-private and multi-stakeholder mechanisms for linking fundamental research, entrepreneurship and innovation with emerging technologies for development, especially in the life sciences and in nanotechnology. He served as General Counsel for International Trade at the U.S. Commerce Department, where he was responsible for both U.S. trade policy and international technology issues. He serves as the Chairman or Vice-Chairman of three committees with the Business and Industry Advisory Committee to the Organisation for Economic Co-operation and Development: Technology, Biotechnology and Life Sciences, and Nanotechnology. Rick also is a member of the MIT Corporation Visiting Committee, the Brown Corporation’s Advisory Council on Biology and Medicine and its Brain Sciences Institute, the MIT Global Innovation Initiative, and several advisory groups focused on the changing nature of S&T policy and innovation in a new era of convergence, complexity, and computation. He also is a co-chair of the National Academies' synthetic biology project, a Director of the BioBricks Foundation, and a frequent participant with the U.S. State Department's S&T global outreach projects. In addition to synthetic biology, he currently is involved in a number of global policy initiatives related to emerging infrastructure for global RD&D, new policy projects related to linking "big data" and societal grand challenges, and public-private models for converging technologies to address global health needs. Mr. Johnson received his M.S. from the Massachusetts Institute of Technology where he was a National Science Foundation National Fellow and his undergraduate degree with Highest Honors from Brown.
Dr. Kristala L. Jones Prather
Massachusetts Institute of Technology
Kristala Jones Prather is the Theodore T. Miller Associate Professor of Chemical Engineering at MIT and an investigator in the multi-institutional Synthetic Biology Engineering Research Center (SynBERC) funded by the National Science Foundation (USA). She received an S.B. degree from MIT in 1994 and Ph.D. from the University of California, Berkeley (1999), and worked 4 years in BioProcess Research and Development at the Merck Research Labs (Rahway, NJ) prior to joining the faculty of MIT. Her research interests are centered on the design and assembly of recombinant microorganisms for the production of small molecules, with additional efforts in novel bioprocess design approaches. Research combines the traditions of metabolic engineering with the practices of biocatalysis to expand and optimize the biosynthetic capacity of microbial systems. A particular focus is the elucidation of design principles for the production of unnatural organic compounds within the framework of the burgeoning field of synthetic biology. Prather is the recipient of a Camille and Henry Dreyfus Foundation New Faculty Award (2004), an Office of Naval Research Young Investigator Award (2005), a Technology Review “TR35” Young Innovator Award (2007), a National Science Foundation CAREER Award (2010), and the Biochemical Engineering Journal Young Investigator Award (2011). Additional honors include selection as the Van Ness Lecturer at Rensselaer Polytechnic Institute (2012) and a Young Scientist of the World Economic Forum Annual Meeting of the New Champions (2012). Prather has been recognized for excellence in teaching with the C. Michael Mohr Outstanding Faculty Award for Undergraduate Teaching in the Dept. of Chemical Engineering (2006) and the MIT School of Engineering Junior Bose Award for Excellence in Teaching (2010).
Jay D. Keasling
University of California, Berkeley
Dr. Jay D. Keasling is a Professor of Chemical Engineering and Bioengineering at the University of California, Berkeley. He is also Acting Deputy Laboratory Director of the Lawrence Berkeley National Laboratory, the Founding Director of the Synthetic Biology Department at UC Berkeley, and chief executive officer of the Joint BioEnergy Institute. He co-founded Codon Devices Inc. in 2004 and Amyris, Inc. (formerly Amyris Biotechnologies, Inc.) in 2003. He is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering. Other, related research interests include Systems Biology and Environmental Biotechnology. Keasling's current research involves the metabolic engineering of the Escherichia coli bacterium, to produce the anti-malarial drug artemisinin. Although it is an effective, proven treatment for malaria, current methods of producing artemisinin (found naturally in the plant Artemisia annua) are considered too expensive to cost-effectively eliminate malaria from developing countries. Jay Keasling received his Bachelor's Degree at the University of Nebraska-Lincoln. He received his Ph.D. from the University of Michigan in 1991. He did post-doctoral work at Stanford University in Biochemistry from 1991 to 1992.
Stephen S. Laderman
Stephen Laderman, Ph.D. is Director of the Molecular Tools Laboratory at Agilent Laboratories. He directs R&D programs aimed at inventing and developing leading-edge measurement solutions for research and diagnostics. His Lab applies biology, chemistry, and computer science expertise to the investigation and development of novel reagents, assay protocols, and computational methods that enable new methods in emerging fields within molecular cellular biology, molecular medicine and synthetic biology. After receiving his A.B. from Wesleyan University in Physics and his Ph.D. from Stanford University in Materials Science and Engineering, Laderman joined Hewlett-Packard (HP) Laboratories in 1984 as a member of technical staff, subsequently holding a variety of research and management positions there and in technology intensive businesses.
Pilar N. Ossorio
University of Wisconsin-Madison
Dr. Ossorio is Professor of Law and Bioethics at the University of Wisconsin, Madison (UW), where she is on the faculties of the Law School and the Department of Medical History and Bioethics at the Medical School. In 2011, she became the inaugural Ethics Scholar-in-Residence at the Morgridge Institute for Research, the private, nonprofit research institute that is part of the Wisconsin Institutes of Discovery. She also serves as the co-director of UW's Law and Neuroscience Program, as a faculty member in the UW Masters in Biotechnology Studies program, and as Program Faculty in the Graduate Program in Population Health. Prior to taking her position at UW, she was Director of the Genetics Section of the Institute for Ethics at the American Medical Association, and taught as adjunct faculty at the University of Chicago Law School. Dr. Ossorio received her Ph.D. in Microbiology and Immunology in 1990 from Stanford University. She went on to complete a post-doctoral fellowship in cell biology at Yale University School of Medicine. Throughout the 1990's, Dr. Ossorio also worked as a consultant for the federal program on the Ethical, Legal, and Social Implications (ELSI) of the Human Genome Project, and in 1994 she took a full time position with the Department of Energy's ELSI program. In 1993 she served on the Ethics Working Group for President Clinton's Health Care Reform Task Force. She received her JD from the University of California at Berkeley School of Law in 1997. While at Berkeley, she was elected to the legal honor society Order of the Coif and received several awards for outstanding legal scholarship.
Ginkgo Bioworks, Inc.
Dr. Reshma Shetty graduated from MIT with a Ph.D. in Biological Engineering in 2008, during which she worked on building digital logic in cells. Dr. Shetty has been active in synthetic biology for several years and co-organized SB1.0, the first international conference in synthetic biology in 2004. In 2008, Forbes magazine named Reshma one of Eight People Inventing the Future, and in 2011, Fast Company named her one of 100 Most Creative People in Business. Reshma and colleagues have founded synthetic biology company Ginkgo Bioworks, Inc., which makes and sells engineered microorganisms for food, fuels, and pharmaceuticals production.
Christopher A. Voigt
Massachusetts Institute of Technology
Dr. Christopher Voigt is an Associate Professor in the Department of Biological Engineering at the Massachusetts Institute of Technology. He holds a joint appointment as a Chemist Scientist at Lawrence Berkeley National Labs, is an Adjunct Professor of Chemical Engineering at the Korea Advanced Institute of Science and Technology (KAIST), and an Honorary Fellow at Imperial College. Prior to joining MIT, he received his B.SE in Chemical Engineering from the University of Michigan (1998), a Ph.D. in Biochemistry/ Biophysics at the California Institute of Technology (2002), performed postdoctoral work in the Bioengineering Department of the University of California – Berkeley (2003), and was a faculty member in the Department of Pharmaceutical Chemistry at the University of California – San Francisco (2003-2011).
University of Illinois at Urbana-Champaign
Dr. Huimin Zhao is the Centennial Endowed Chair Professor of chemical and biomolecular engineering, and professor of chemistry, biochemistry, biophysics, and bioengineering at the University of Illinois at Urbana-Champaign and the visiting principle investigator of the Metabollic Engineering Research Laboratory (MERL) in the Agency for Science, Technology and Research (A*STAR) of Singapore. Prior to joining the faculty at the University of Illinois in 2000, Dr. Zhao worked at the Dow Chemical company for two years. Zhao’s primary research interests are in the development and application of synthesis biology tools to address society’s most daunting challenges in health, energy, and sustainability, and in the fundamental aspects of enzyme catalysis, cell metabolism, and gene regulation. Dr. Zhao has received numerous research and teaching awards and honors, including Guggenheim Fellowship (2012), Fellow of the American Association for the Advancement of Science (AAAS) (2010), Fellow of the American Institute of Medical and Biological Engineering (AIMBE) (2009), and others. He has authored and co-authored 170 research articles and 20 issued and pending patent applications, several of which are being licensed by industry. In addition, he has given plenary, keynote, or invited lectures in more than 200 international meetings and institutions. Professor Zhao received his B.S. in Biology from the University of Science and Technology of China in 1992. He earned a Ph.D. in Chemistry from the California Institute of Technology in 1998.